Prime Medicine, Inc. Common Stock (NASDAQ: PRME) last traded at $3.39, up 4.63% on the session. The quote above updates while this page is open; the figures below are drawn from Prime Medicine, Inc. Common Stock’s own filings and are restated only when a new one is published.
Prime Medicine, Inc. Common Stock trades on NASDAQ under the ticker PRME. Its market capitalisation is $614.87 million.
Valuation measures for Prime Medicine, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $614.87M |
|---|---|
| Enterprise value | $776.65M |
| Price / sales | 132.74 |
| Price / book | 15.45 |
| Beta | 2.24 |
Trailing-twelve-month figures tagged in Prime Medicine, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.63M |
|---|---|
| Net income (TTM) | -$187.89M |
| EPS (TTM) | -$1.06 |
| Operating margin | -4242.66% |
| Return on equity | -471.98% |
| Cash | $47.45M |
Range and volume for PRME over the past 52 weeks.
| 52-week high | $6.94 |
|---|---|
| 52-week low | $2.67 |
| Volume | 3.58M |
| Average volume | 3.36M |
| Previous close | $3.24 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.